Stryker Corp (SYK) Stock Price & Analysis
Stryker Corp (SYK) rose 3.54% to USD 330.25 as of July 25, 2026 at 01:12 UTC, according to Nexqual real-time market data.
SYK last closed at USD 318.97; the session ranged USD 324.02–330.8 on volume of 2,261,042 shares. Market capitalization is $126.60B, with a 52-week range of USD 281–404.14 (NYQ). Source: Nexqual, July 25, 2026 at 01:12 UTC.
Key Statistics (as of July 25, 2026 at 01:12 UTC)
| Price | USD 330.25 |
|---|---|
| Change | ▲ 3.54% (up) |
| Previous Close | USD 318.97 |
| Open | USD 325.08 |
| Day Range | USD 324.02 – 330.8 |
| 52-Week Range | USD 281 – 404.14 |
| Volume | 2,261,042 shares |
| Market Cap | $126.60B |
| Exchange | NYQ |
Technical Analysis (SYK)
Nexqual's technical model rates SYK "BUY" based on 5 bullish and 1 bearish signals across 125 daily candles, as of July 25, 2026 at 01:12 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 56.6 (neutral) |
| vs SMA50 | Above (USD 313.91) |
| MACD | 1.63 (positive) |
Analyst Ratings (SYK)
Wall Street analysts rate SYK "Buy" based on 25 analysts, with a mean price target of USD 386.52 (range USD 315–465), per Nexqual as of July 25, 2026 at 01:12 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 25 |
| Mean Target | USD 386.52 |
| High Target | USD 465 |
| Low Target | USD 315 |
| Buy / Hold / Sell | 22 / 5 / 0 |
Earnings (SYK)
| Next Earnings Date | 2026-07-30 |
|---|---|
| EPS Estimate | USD 3.49 |
| Revenue Estimate | $6.58B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 2.6 vs est 2.98 ▼ miss |
| 2025-12-31 | USD 4.47 vs est 4.4 ▲ beat |
| 2025-09-30 | USD 3.19 vs est 3.13 ▲ beat |
| 2025-06-30 | USD 3.13 vs est 3.07 ▲ beat |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Financials & Fundamentals (SYK)
| Total Revenue | $25.27B |
|---|---|
| Revenue Growth (YoY) | +2.60% |
| Gross Margin | +64.70% |
| Operating Margin | +17.82% |
| Profit Margin | +13.21% |
| ROE | +15.20% |
| Debt / Equity | 66.3 |
| Current Ratio | 2.11 |
| Total Cash | $2.96B |
| Total Debt | $15.23B |
| Free Cash Flow | $4.36B |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
Financial Health Score (SYK)
Nexqual rates Stryker Corp's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 01:12 UTC.
| Growth | Solid — Revenue +11% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 65%, operating 18% |
| Balance Sheet | Strong — $2.96B cash vs $15.2B debt |
| Cash Flow | Strong — FCF $4.36B, 17% margin |
| Efficiency | Solid — ROE 15%, ROA 7.7% |
Ownership (SYK)
| Insider Ownership | +5.37% |
|---|---|
| Institutional Ownership | +82.10% |
| Shares Outstanding | 383.36M |
| Float | 347.57M |
| Short % of Float | +1.88% |
Source: Nexqual, July 25, 2026 at 01:12 UTC.
From Stryker Corp's Latest SEC 10-K Filing (filed 2026-02-11)
Key Strengths & Strategy (as disclosed to the SEC)
- Stryker Corporation operates as a medical technology company in the United States and internationally.
- It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics.
- The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, ankle, and trauma and extremities surgeries; and Mako Shoulder, which expands the smart robotics suite of applications.
- The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 61 countries.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MDT | Medtronic plc. | USD 83.21 | ▲ 1.61% |
| BDX | Becton, Dickinson and Company | USD 156.36 | ▲ 2.09% |
| TMO | Thermo Fisher Scientific Inc | USD 568.26 | ▲ 7.94% |
| BSX | Boston Scientific Corporation | USD 44.25 | ▲ 2.98% |
| DHR | Danaher Corporation | USD 191.5 | ▲ 6.9% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 01:12 UTC. This page is informational and not investment advice.